ClinicalTrials.gov
ClinicalTrials.gov Menu

Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02) (PXS-X02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00235482
Recruitment Status : Completed
First Posted : October 10, 2005
Last Update Posted : January 12, 2018
Sponsor:
Information provided by (Responsible Party):
Viralytics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 21, 2006
  Actual Study Completion Date : April 21, 2006